6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide

C140H202N36O13 — CID 161065171

IUPAC6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide
SMILESCC(C)N1CCC(NC(=O)c2cnc3nc2NCCCC(O)CCCCCN3)CC1.COc1cc(C)cc(CNC(=O)c2cnc3nc2NCCCC(O)CCCCCN3)c1.Cc1ccc(CNC(=O)c2cnc3nc2NCCCCC(O)CCCCCCCCCN3)cc1.Cc1ccc(NC(=O)c2cnc3nc2NCCCC(O)CCCCCN3)cc1.O=C(NCc1ccc(-n2cccn2)nc1)c1cnc2nc1NCCCC(O)CCCCCN2.O=C(NCc1ccc(-n2ccnc2)cc1)c1cnc2nc1NCCCC(O)CCCCCN2
InChIInChI=1S/C27H41N5O2.C24H31N7O2.C23H30N8O2.C23H33N5O3.C22H38N6O2.C21H29N5O2/c1-21-13-15-22(16-14-21)19-30-26(34)24-20-31-27-29-18-9-6-4-2-3-5-7-11-23(33)12-8-10-17-28-25(24)32-27;32-20-5-2-1-3-11-27-24-29-16-21(22(30-24)26-12-4-6-20)23(33)28-15-18-7-9-19(10-8-18)31-14-13-25-17-31;32-18-6-2-1-3-10-25-23-28-16-19(21(30-23)24-11-4-7-18)22(33)27-15-17-8-9-20(26-14-17)31-13-5-12-29-31;1-16-11-17(13-19(12-16)31-2)14-26-22(30)20-15-27-23-25-9-5-3-4-7-18(29)8-6-10-24-21(20)28-23;1-16(2)28-13-9-17(10-14-28)26-21(30)19-15-25-22-24-11-5-3-4-7-18(29)8-6-12-23-20(19)27-22;1-15-8-10-16(11-9-15)25-20(28)18-14-24-21-23-12-4-2-3-6-17(27)7-5-13-22-19(18)26-21/h13-16,20,23,33H,2-12,17-19H2,1H3,(H,30,34)(H2,28,29,31,32);7-10,13-14,16-17,20,32H,1-6,11-12,15H2,(H,28,33)(H2,26,27,29,30);5,8-9,12-14,16,18,32H,1-4,6-7,10-11,15H2,(H,27,33)(H2,24,25,28,30);11-13,15,18,29H,3-10,14H2,1-2H3,(H,26,30)(H2,24,25,27,28);15-18,29H,3-14H2,1-2H3,(H,26,30)(H2,23,24,25,27);8-11,14,17,27H,2-7,12-13H2,1H3,(H,25,28)(H2,22,23,24,26)
InChIKeyUDXUJSTZGREALA-UHFFFAOYSA-N
MW2597.39 g/mol
LogP20.32
Rot. Bonds20

About 6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide

6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide (PubChem CID 161065171) has the molecular formula C140H202N36O13 and a molecular weight of 2597.39 g/mol. Its IUPAC name is 6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide.

Molecular Properties

Compound Name6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide
PubChem CID161065171
Molecular FormulaC140H202N36O13
Molecular Weight2597.39 g/mol
Exact Mass2595.63
IUPAC Name6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide
SMILESCC(C)N1CCC(NC(=O)c2cnc3nc2NCCCC(O)CCCCCN3)CC1.COc1cc(C)cc(CNC(=O)c2cnc3nc2NCCCC(O)CCCCCN3)c1.Cc1ccc(CNC(=O)c2cnc3nc2NCCCCC(O)CCCCCCCCCN3)cc1.Cc1ccc(NC(=O)c2cnc3nc2NCCCC(O)CCCCCN3)cc1.O=C(NCc1ccc(-n2cccn2)nc1)c1cnc2nc1NCCCC(O)CCCCCN2.O=C(NCc1ccc(-n2ccnc2)cc1)c1cnc2nc1NCCCC(O)CCCCCN2
InChIInChI=1S/C27H41N5O2.C24H31N7O2.C23H30N8O2.C23H33N5O3.C22H38N6O2.C21H29N5O2/c1-21-13-15-22(16-14-21)19-30-26(34)24-20-31-27-29-18-9-6-4-2-3-5-7-11-23(33)12-8-10-17-28-25(24)32-27;32-20-5-2-1-3-11-27-24-29-16-21(22(30-24)26-12-4-6-20)23(33)28-15-18-7-9-19(10-8-18)31-14-13-25-17-31;32-18-6-2-1-3-10-25-23-28-16-19(21(30-23)24-11-4-7-18)22(33)27-15-17-8-9-20(26-14-17)31-13-5-12-29-31;1-16-11-17(13-19(12-16)31-2)14-26-22(30)20-15-27-23-25-9-5-3-4-7-18(29)8-6-10-24-21(20)28-23;1-16(2)28-13-9-17(10-14-28)26-21(30)19-15-25-22-24-11-5-3-4-7-18(29)8-6-12-23-20(19)27-22;1-15-8-10-16(11-9-15)25-20(28)18-14-24-21-23-12-4-2-3-6-17(27)7-5-13-22-19(18)26-21/h13-16,20,23,33H,2-12,17-19H2,1H3,(H,30,34)(H2,28,29,31,32);7-10,13-14,16-17,20,32H,1-6,11-12,15H2,(H,28,33)(H2,26,27,29,30);5,8-9,12-14,16,18,32H,1-4,6-7,10-11,15H2,(H,27,33)(H2,24,25,28,30);11-13,15,18,29H,3-10,14H2,1-2H3,(H,26,30)(H2,24,25,27,28);15-18,29H,3-14H2,1-2H3,(H,26,30)(H2,23,24,25,27);8-11,14,17,27H,2-7,12-13H2,1H3,(H,25,28)(H2,22,23,24,26)
InChIKeyUDXUJSTZGREALA-UHFFFAOYSA-N
XLogP20.32
TPSA656.02 Ų
H-Bond Donors24
H-Bond Acceptors43
Rotatable Bonds20
Heavy Atoms189
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002597.39
LogP ≤ 520.32
H-Bond Donors ≤ 524
H-Bond Acceptors ≤ 1043

Analyze 6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide?
The IUPAC name of 6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide (CID 161065171) is 6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide.
What is the SMILES notation for 6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide?
The canonical SMILES for 6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide is CC(C)N1CCC(NC(=O)c2cnc3nc2NCCCC(O)CCCCCN3)CC1.COc1cc(C)cc(CNC(=O)c2cnc3nc2NCCCC(O)CCCCCN3)c1.Cc1ccc(CNC(=O)c2cnc3nc2NCCCCC(O)CCCCCCCCCN3)cc1.Cc1ccc(NC(=O)c2cnc3nc2NCCCC(O)CCCCCN3)cc1.O=C(NCc1ccc(-n2cccn2)nc1)c1cnc2nc1NCCCC(O)CCCCCN2.O=C(NCc1ccc(-n2ccnc2)cc1)c1cnc2nc1NCCCC(O)CCCCCN2.
What is the InChIKey of 6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide?
The InChIKey is UDXUJSTZGREALA-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H41N5O2.C24H31N7O2.C23H30N8O2.C23H33N5O3.C22H38N6O2.C21H29N5O2/c1-21-13-15-22(16-14-21)19-30-26(34)24-20-31-27-29-18-9-6-4-2-3-5-7-11-23(33)12-8-10-17-28-25(24)32-27;32-20-5-2-1-3-11-27-24-29-16-21(22(30-24)26-12-4-6-20)23(33)28-15-18-7-9-19(10-8-18)31-14-13-25-17-31;32-18-6-2-1-3-10-25-23-28-16-19(21(30-23)24-11-4-7-18)22(33)27-15-17-8-9-20(26-14-17)31-13-5-12-29-31;1-16-11-17(13-19(12-16)31-2)14-26-22(30)20-15-27-23-25-9-5-3-4-7-18(29)8-6-10-24-21(20)28-23;1-16(2)28-13-9-17(10-14-28)26-21(30)19-15-25-22-24-11-5-3-4-7-18(29)8-6-12-23-20(19)27-22;1-15-8-10-16(11-9-15)25-20(28)18-14-24-21-23-12-4-2-3-6-17(27)7-5-13-22-19(18)26-21/h13-16,20,23,33H,2-12,17-19H2,1H3,(H,30,34)(H2,28,29,31,32);7-10,13-14,16-17,20,32H,1-6,11-12,15H2,(H,28,33)(H2,26,27,29,30);5,8-9,12-14,16,18,32H,1-4,6-7,10-11,15H2,(H,27,33)(H2,24,25,28,30);11-13,15,18,29H,3-10,14H2,1-2H3,(H,26,30)(H2,24,25,27,28);15-18,29H,3-14H2,1-2H3,(H,26,30)(H2,23,24,25,27);8-11,14,17,27H,2-7,12-13H2,1H3,(H,25,28)(H2,22,23,24,26).
What are the key properties of 6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide?
6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide has a molecular weight of 2597.39 g/mol, XLogP of 20.32, 20 rotatable bonds, 24 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for 6-hydroxy-N-[(4-imidazol-1-ylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(3-methoxy-5-methylphenyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;7-hydroxy-N-[(4-methylphenyl)methyl]-2,17,19,22-tetrazabicyclo[16.3.1]docosa-1(22),18,20-triene-21-carboxamide;6-hydroxy-N-(4-methylphenyl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-(1-propan-2-ylpiperidin-4-yl)-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide;6-hydroxy-N-[(6-pyrazol-1-yl-3-pyridinyl)methyl]-2,12,14,17-tetrazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-16-carboxamide is sourced from PubChem (CID 161065171), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).